Disaggregated Revenues (Tables)

9 Months Ended

Sep. 30, 2022

Disaggregation of Revenue [Abstract]

Summary of disaggregation of revenues by nature

The following table summarizes the disaggregation of revenues by product or source (dollars in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
	(unaudited)				(unaudited)
Net product sales
Trokendi XR	$	69,599	$	80,935	$	204,033	$	231,531
Oxtellar XR	30,528		29,728		88,007		82,120
GOCOVRI	27,878		—		75,179		—
Qelbree	18,326		2,370		37,708		2,685
APOKYN	$	18,261	$	24,627	$	57,156	$	73,338
Other(1)	8,132		7,872		23,564		22,867
Total net product sales	$	172,724	$	145,532	$	485,647	$	412,541
Royalty revenues	4,629		2,932		14,263		8,184
Total revenues	$	177,353	$	148,464	$	499,910	$	420,725

______________________________

(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.